2m 2m 2m 2m 2m 2m 2m
- N/AMarket Cap
- -100.00%1-Year Change
- Medical DevicesIndustry
Work Medical-A (WOK)
Key Performance
More- Earnings Score: N/A
- Momentum Score: 56
- True Yield: N/A
- Financial Health Score: N/A
Latest Research & News
WORK Medical Technology Group LTD announced a 1-for-100 reverse stock split effective December 29, 2025, to maintain compliance with Nasdaq's minimum bid price requirement. The reverse split will combine every 100 shares into 1 share, with fractional shares rounded up. The company continues to operate as a medical device supplier in China with products sold across 34 provincial regions and 15 countries.
12/24/2025, 11:30 AM • GlobeNewswire
WORK Medical Technology Group LTD Granted Additional 180-Day Period to Regain Nasdaq Compliance
WORK Medical received a 180-day extension from Nasdaq to regain compliance with minimum bid price requirements, with potential options including a reverse stock split to maintain its listing.
10/10/2025, 9:00 AM • GlobeNewswire
Univest Securities completed a $2.9 million registered direct offering for WORK Medical Technology Group, selling 38,999,334 Class A ordinary shares at $0.075 per share.
09/26/2025, 5:00 PM • GlobeNewswire
WORK Medical Technology Group signed a strategic cooperation agreement with Xin Rui Hospital to develop AI-powered medical products, aiming to advance hospital digitalization and create an intelligent clinical ecosystem through multimodal data integration.
09/22/2025, 9:00 AM • GlobeNewswire
Peers
Statistics
MoreInformation as of 06/02/2026
Company Profile
WORK Medical Technology Group LTD, through with its subsidiaries, manufactures and sells medical consumables and devices in the People's Republic of China and internationally. The company offers medical face masks, artery compression tourniquets, endotracheal tube holders, intubating stylets, and guedel airways, etc.; disposable breathing circuits, laryngeal mask airways, endotracheal tubes, anesthetic kits, oxygen face masks, heat and moisture exchanging filters, anesthesia masks, laryngoscope blades, yankauer suction sets, and nasal oxygen cannulas; other medical devices, such as KN95 masks and filtering half masks; visualized prostatic dilatation catheters; and nebulizer kits, SPO2 sensors, nasogastric tubes, personal protective equipment, hygiene and skincare products, cleaners for household use, and non-powered air-purifying particle respirators. It also engages in the research and development of biological and medical technology; and sale of chemical products. The company serves hospitals, pharmacies, and medical institutions. It exports its products to approximately 30 countries in Asia, Africa, Europe, North America, South America, and Oceania. WORK Medical Technology Group LTD has strategic cooperation agreement with Shanghai Novabioplus Biotechnology Co., Ltd. to develop data-model-application trinity for intelligent medical models. WORK Medical Technology Group LTD was founded in 2002 and is based in Hangzhou City, China.
Key Executives
- Shuang Wu
- Ningfang Liang
- Baiming Yu
Current Ownership Distribution
- Institutions3.4M (97.15%)
- Insiders100,625 (2.85%)
- Mutual Funds0 (0.00%)
- Other0 (0.00%)